BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20693965)

  • 1. Genetic and epigenetic changes of NKIRAS1 gene in human renal cell carcinomas.
    Gerashchenko GV; Bogatyrova OO; Rudenko EE; Kondratov AG; Gordiyuk VV; Zgonnyk YM; Vozianov OF; Pavlova TV; Zabarovsky ER; Rynditch AV; Kashuba VI
    Exp Oncol; 2010 Jul; 32(2):71-5. PubMed ID: 20693965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of the candidate tumor suppressor gene HOXB13 in human renal cell carcinoma.
    Okuda H; Toyota M; Ishida W; Furihata M; Tsuchiya M; Kamada M; Tokino T; Shuin T
    Oncogene; 2006 Mar; 25(12):1733-42. PubMed ID: 16278676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aberrant methylation of tumor suppressor genes in renal cell carcinoma].
    Zhang Q; Jin J; Tao Q
    Ai Zheng; 2007 Nov; 26(11):1276-80. PubMed ID: 17991333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening of novel genes differentially expressed in human renal cell carcinoma by suppression subtractive hybridization].
    Ai JK; Huang X; Wang YJ; Bai Y; Lu YQ; Ye XJ; Xin DQ; Na YQ; Zhang ZW; Guo YL
    Ai Zheng; 2002 Oct; 21(10):1065-9. PubMed ID: 12508644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multigene methylation analysis of conventional renal cell carcinoma.
    Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
    Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-associated silencing of TU3A in human cancers.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Int J Oncol; 2008 Oct; 33(4):893-9. PubMed ID: 18813805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma.
    Hirota E; Yan L; Tsunoda T; Ashida S; Fujime M; Shuin T; Miki T; Nakamura Y; Katagiri T
    Int J Oncol; 2006 Oct; 29(4):799-827. PubMed ID: 16964377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
    Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
    Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of transcript for brain-type fatty Acid-binding protein in tumor and urine of patients with renal cell carcinoma.
    Teratani T; Domoto T; Kuriki K; Kageyama T; Takayama T; Ishikawa A; Ozono S; Nozawa R
    Urology; 2007 Feb; 69(2):236-40. PubMed ID: 17320655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
    Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
    Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
    J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.